Compare $BYSI vs $MCRB | Chartloom

Compare

$BYSI vs $MCRB

Beyondspring Inc · Seres Therapeutics Inc

BYSI

Beyondspring Inc

MCRB

Seres Therapeutics Inc

Compare $BYSI vs $MCRB

Comparing Beyondspring Inc and Seres Therapeutics Inc

BYSIBeyondspring Inc

MCRBSeres Therapeutics Inc

BYSIBeyondspring Inc

Market cap

$25M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.4%

52W performance

-66.2%

FCF yield

-67.2%

MCRBSeres Therapeutics Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-82.1%

52W performance

-86.2%

FCF yield

-195.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BYSI

MCRB

Detailed metrics comparison

BYSI

Beyondspring Inc

MCRB

Seres Therapeutics Inc

Market Cap

BYSI$25M

MCRB$26M

Enterprise Value

BYSI$22M

MCRB$11M

Price

BYSI$0.61

MCRB$2.71

P/E Ratio

BYSIN/A

MCRBN/A

P/S Ratio

BYSI23.96x

MCRB13.93x

EV/Sales

BYSI21.97x

MCRB5.65x

EV/EBITDA

BYSI0.00x

MCRB0.00x

P/B Ratio

BYSI3.99x

MCRB0.85x

P/FCF Ratio

BYSIN/A

MCRBN/A

EV/FCF

BYSI-1.33x

MCRB-0.21x

PEG Ratio

BYSIN/A

MCRBN/A

Forward P/E (NTM)

BYSIN/A

MCRBN/A

Forward P/S (NTM)

BYSIN/A

MCRBN/A

Revenue (TTM)

BYSI$0

MCRB$2M

Revenue Growth (YoY)

BYSIN/A

MCRBN/A

Forward Rev Growth

BYSI0.0%

MCRB-98.0%

Gross Margin (TTM)

BYSI0.0%

MCRB0.0%

Operating Margin (TTM)

BYSI0.0%

MCRB0.0%

EBITDA Margin (TTM)

BYSI0.0%

MCRB-3971.2%

Net Margin (TTM)

BYSI0.0%

MCRB-1192.9%

FCF Margin (TTM)

BYSIN/A

MCRB-2724.1%

Net Income (TTM)

BYSI$-7M

MCRB$-22M

FCF (TTM)

BYSI$-17M

MCRB$-51M

EPS (TTM)

BYSI-$0.16

MCRB-$2.30

ROE (TTM)

BYSI-13313.0%

MCRB-6032.0%

ROA (TTM)

BYSI-3024.0%

MCRB-1794.0%

ROIC (TTM)

BYSI-12817.0%

MCRB-6032.0%

Cash

BYSI$3M

MCRB$16M

Debt

BYSI$0

MCRB$0

Net Cash/Debt

BYSI$3M

MCRB$16M

Current Ratio (TTM)

BYSI0.70x

MCRB2.11x

Quick Ratio (TTM)

BYSI0.66x

MCRB2.04x

Debt/Equity (TTM)

BYSI0.06x

MCRB0.00x

Debt/Assets (TTM)

BYSI0.0%

MCRB0.0%

Interest Coverage (TTM)

BYSIN/A

MCRBN/A

Net Debt/EBITDA (TTM)

BYSI0.00x

MCRB0.00x

Beta

BYSI-0.26

MCRB0.49

52W Performance

BYSI-66.2%

MCRB-86.2%

YTD Performance

BYSI-62.4%

MCRB-82.1%

% from 52W High

BYSI-75.2%

MCRB-91.0%

% from 52W Low

BYSI7.1%

MCRB12.0%

Asset Turnover (TTM)

BYSI0.02x

MCRB0.02x

FCF Yield (TTM)

BYSI-67.2%

MCRB-195.5%

Earnings Yield (TTM)

BYSI-26.8%

MCRB-85.6%

Dividend Yield (TTM)

BYSIN/A

MCRBN/A

Rule of 40

BYSI0.0

MCRB-2,724.1

EV/GP/RG

BYSIN/A

MCRBN/A

Ticker research

View BYSI research View MCRB research

Metric	BYSI Beyondspring Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$25M	$26M
Enterprise Value	$22M	$11M
Price	$0.61	$2.71
P/E Ratio	N/A	N/A
P/S Ratio	23.96x	13.93x
EV/Sales	21.97x	5.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-98.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3971.2%
Net Margin (TTM)	0.0%	-1192.9%
FCF Margin (TTM)	N/A	-2724.1%
Net Income (TTM)	$-7M	$-22M
FCF (TTM)	$-17M	$-51M
EPS (TTM)	-$0.16	-$2.30
ROE (TTM)	-13313.0%	-6032.0%
ROA (TTM)	-3024.0%	-1794.0%
ROIC (TTM)	-12817.0%	-6032.0%
Financial Health
Cash	$3M	$16M
Debt	$0	$0
Net Cash/Debt	$3M	$16M
Current Ratio (TTM)	0.70x	2.11x
Quick Ratio (TTM)	0.66x	2.04x
Debt/Equity (TTM)	0.06x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.26	0.49
52W Performance	-66.2%	-86.2%
YTD Performance	-62.4%	-82.1%
% from 52W High	-75.2%	-91.0%
% from 52W Low	7.1%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.02x
FCF Yield (TTM)	-67.2%	-195.5%
Earnings Yield (TTM)	-26.8%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View BYSI research	View MCRB research

Valuation

P/S Ratio

MCRB

13.93x

BYSI

23.96x

EV/FCF

BYSI

-1.33x

MCRB

-0.21x

Growth & revenue

Forward Revenue Growth

BYSI

0.0%

MCRB

-98.0%

Profitability & performance

Gross Margin

BYSI

0.0%

MCRB

0.0%

ROE

MCRB

-6032.0%

BYSI

-13313.0%

FCF Yield %

BYSI

-67.2%

MCRB

-195.5%

52-Week Performance

BYSI

-66.2%

MCRB

-86.2%

Detailed metrics comparison

BYSI

Beyondspring Inc

MCRB

Seres Therapeutics Inc

Market Cap

BYSI$25M

MCRB$26M

Enterprise Value

BYSI$22M

MCRB$11M

Price

BYSI$0.61

MCRB$2.71

P/E Ratio

BYSIN/A

MCRBN/A

P/S Ratio

BYSI23.96x

MCRB13.93x

EV/Sales

BYSI21.97x

MCRB5.65x

EV/EBITDA

BYSI0.00x

MCRB0.00x

P/B Ratio

BYSI3.99x

MCRB0.85x

P/FCF Ratio

BYSIN/A

MCRBN/A

EV/FCF

BYSI-1.33x

MCRB-0.21x

PEG Ratio

BYSIN/A

MCRBN/A

Forward P/E (NTM)

BYSIN/A

MCRBN/A

Forward P/S (NTM)

BYSIN/A

MCRBN/A

Revenue (TTM)

BYSI$0

MCRB$2M

Revenue Growth (YoY)

BYSIN/A

MCRBN/A

Forward Rev Growth

BYSI0.0%

MCRB-98.0%

Gross Margin (TTM)

BYSI0.0%

MCRB0.0%

Operating Margin (TTM)

BYSI0.0%

MCRB0.0%

EBITDA Margin (TTM)

BYSI0.0%

MCRB-3971.2%

Net Margin (TTM)

BYSI0.0%

MCRB-1192.9%

FCF Margin (TTM)

BYSIN/A

MCRB-2724.1%

Net Income (TTM)

BYSI$-7M

MCRB$-22M

FCF (TTM)

BYSI$-17M

MCRB$-51M

EPS (TTM)

BYSI-$0.16

MCRB-$2.30

ROE (TTM)

BYSI-13313.0%

MCRB-6032.0%

ROA (TTM)

BYSI-3024.0%

MCRB-1794.0%

ROIC (TTM)

BYSI-12817.0%

MCRB-6032.0%

Cash

BYSI$3M

MCRB$16M

Debt

BYSI$0

MCRB$0

Net Cash/Debt

BYSI$3M

MCRB$16M

Current Ratio (TTM)

BYSI0.70x

MCRB2.11x

Quick Ratio (TTM)

BYSI0.66x

MCRB2.04x

Debt/Equity (TTM)

BYSI0.06x

MCRB0.00x

Debt/Assets (TTM)

BYSI0.0%

MCRB0.0%

Interest Coverage (TTM)

BYSIN/A

MCRBN/A

Net Debt/EBITDA (TTM)

BYSI0.00x

MCRB0.00x

Beta

BYSI-0.26

MCRB0.49

52W Performance

BYSI-66.2%

MCRB-86.2%

YTD Performance

BYSI-62.4%

MCRB-82.1%

% from 52W High

BYSI-75.2%

MCRB-91.0%

% from 52W Low

BYSI7.1%

MCRB12.0%

Asset Turnover (TTM)

BYSI0.02x

MCRB0.02x

FCF Yield (TTM)

BYSI-67.2%

MCRB-195.5%

Earnings Yield (TTM)

BYSI-26.8%

MCRB-85.6%

Dividend Yield (TTM)

BYSIN/A

MCRBN/A

Rule of 40

BYSI0.0

MCRB-2,724.1

EV/GP/RG

BYSIN/A

MCRBN/A

Ticker research

View BYSI research View MCRB research

Metric	BYSI Beyondspring Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$25M	$26M
Enterprise Value	$22M	$11M
Price	$0.61	$2.71
P/E Ratio	N/A	N/A
P/S Ratio	23.96x	13.93x
EV/Sales	21.97x	5.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-98.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3971.2%
Net Margin (TTM)	0.0%	-1192.9%
FCF Margin (TTM)	N/A	-2724.1%
Net Income (TTM)	$-7M	$-22M
FCF (TTM)	$-17M	$-51M
EPS (TTM)	-$0.16	-$2.30
ROE (TTM)	-13313.0%	-6032.0%
ROA (TTM)	-3024.0%	-1794.0%
ROIC (TTM)	-12817.0%	-6032.0%
Financial Health
Cash	$3M	$16M
Debt	$0	$0
Net Cash/Debt	$3M	$16M
Current Ratio (TTM)	0.70x	2.11x
Quick Ratio (TTM)	0.66x	2.04x
Debt/Equity (TTM)	0.06x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.26	0.49
52W Performance	-66.2%	-86.2%
YTD Performance	-62.4%	-82.1%
% from 52W High	-75.2%	-91.0%
% from 52W Low	7.1%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.02x
FCF Yield (TTM)	-67.2%	-195.5%
Earnings Yield (TTM)	-26.8%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View BYSI research	View MCRB research